| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999583 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
Age and BMI are additional independent prognostic factors for patients with mRCC receiving vascular endothelial growth factor receptor-targeted TKI treatment, and the MSKCC prognostic model is also applicable to them. A 7-factor prognostic model might help to identify patients with the best prognosis. Further studies are needed to confirm these findings.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Yan M.D., Chunxia M.D., Wen M.D., Yongkun M.D., Lin M.D., Chengxu M.D., Yihebali M.D., Jianzhong M.D., Aiping M.D., Jinwan M.D., Yan M.D.,